Cross Icon

Press Releases

Your source for Evernorth news.

Cross Icon
Featured

Evernorth announces another step forward in lowering drug prices by making a Stelara biosimilar available at $0 out of pocket for patients early next year

  • Estimated to save individual Accredo patients around $4,000 per year
  • Biosimilar price will be more than 80% lower than Stelara list price
  • Accredo patients benefit from the specialty pharmacy’s best-in-class clinical support
Read more
""

Filter Press Releases

Media contact:

media@evernorth.com
Press Release

HL7’s Accelerator CodeX Launches Pilot to Simplify Prior Authorizations in Oncology

Evernorth, Varian Lead Interoperability Efforts between Payers and Providers.

August 31, 22

Read More
Press Release

Evernorth and Kaiser Permanente Enter Strategic Collaboration to Deliver More Convenient, Affordable and Accessible Health Care

Broad agreement aims to increase convenience and expand affordable access to valuable health benefits and high-quality care to millions more Americans Kaiser Permanente members will benefit from ac...

April 19, 22

Read More
Press Release

Evernorth and Behavioral Health Center of Excellence Collaborate to Measure Health Outcomes for Autism Treatment

First-of-its-kind partnership will establish quality performance metrics to drive improvements in quality of therapy for autism spectrum disorder

April 14, 22

Read More
Press Release

With Heavy Alcohol Use Increasing, Evernorth Expands Access To Treatment with Monument’s Virtual Services

Through the Evernorth Behavioral Health Network, customers can now use Monument’s online peer support, personalized therapy, and provider-prescribed medication to help them achieve sobriety or moderat...

February 15, 22

Read More
Press Release

Evernorth’s Accredo Earns URAC Rare Disease Pharmacy Center of Excellence Designation

February 10, 22

Read More